Pulse Biosciences, based in Hayward, California, develops proprietary oncolytic electroceutical therapies using Nano Pulse Stimulation (NPS) technology for various medical applications. The company went public on May 18, 2016, and employs 56 staff.
Darrin Uecker sold 25,000 shares of PLSE on 16 September at $16.28 per share, worth a total of $407K. They now own 122,872 PLSE shares, or a 17% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.